Aclaris (ACRS) soared 60% Tuesday, the day after the company announced it was licensing two drug candidates, prompting ...
Aclaris Therapeutics has secured an exclusive license from Biosion for the global rights to two new antibodies.
Therefore, even individuals without childhood eczema may experience it later in life. Dr Grant has debunked the common ...
The CDA-AMC recommended that Ebglyss not be reimbursed by public drug plans, excluding Quebec, for the treatment of moderate-to-severe atopic dermatitis in adults and adolescents 12 years of age and ...
The following is a summary of “Comparative safety of oral Janus kinase inhibitors versus dupilumab in patients with atopic ...
Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activityMore than 300,000 people in the U.S.
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, today ann ...
Natural treatments for lupus are typically used as complementary therapies alongside conventional treatments. Learn more ...
Hosted on MSN5d
Homeopathy: Dermatitis, Its Types And Its TreatmentTypes of dermatitis Dermatitis encompasses various types, each with unique characteristics. Atopic Dermatitis ... may increase the risk. Treatment Homeopathic treatments, derived from natural ...
The novel oral first-in-class anti-inflammatory agent has demonstrated robust efficacy and high safety margins in preclinical studies, and is the first drug candidate to advance to clinical trials ...
The company's FDA-approved drug Sofdra is the first for the common and embarrassing condition of excessive sweating.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback